Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Department of Family Medicine, Lund University, Malmö, Sweden.
Diabetologia. 2021 Jan;64(1):95-108. doi: 10.1007/s00125-020-05279-1. Epub 2020 Sep 26.
AIMS/HYPOTHESIS: Non-Western immigrants to Europe are at high risk for type 2 diabetes. In this nationwide study including incident cases of type 2 diabetes, the aim was to compare all-cause mortality (ACM) and cause-specific mortality (CSM) rates in first- and second-generation immigrants with native Swedes.
People living in Sweden diagnosed with new-onset pharmacologically treated type 2 diabetes between 2006 and 2012 were identified through the Swedish Prescribed Drug Register. They were followed until 31 December 2016 for ACM and until 31 December 2012 for CSM. Analyses were adjusted for age at diagnosis, sex, socioeconomic status, education, treatment and region. Associations were assessed using Cox regression analysis.
In total, 138,085 individuals were diagnosed with type 2 diabetes between 2006 and 2012 and fulfilled inclusion criteria. Of these, 102,163 (74.0%) were native Swedes, 28,819 (20.9%) were first-generation immigrants and 7103 (5.1%) were second-generation immigrants with either one or both parents born outside Sweden. First-generation immigrants had lower ACM rate (HR 0.80 [95% CI 0.76, 0.84]) compared with native Swedes. The mortality rates were particularly low in people born in non-Western regions (0.46 [0.42, 0.50]; the Middle East, 0.41 [0.36, 0.47]; Asia, 0.53 [0.43, 0.66]; Africa, 0.47 [0.38, 0.59]; and Latin America, 0.53 [0.42, 0.68]). ACM rates decreased with older age at migration and shorter stay in Sweden. Compared with native Swedes, first-generation immigrants with ≤ 24 years in Sweden (0.55 [0.51, 0.60]) displayed lower ACM rates than those spending >24 years in Sweden (0.92 [0.87, 0.97]). Second-generation immigrants did not have better survival rates than native Swedes but rather displayed higher ACM rates for people with both parents born abroad (1.28 [1.05, 1.56]).
CONCLUSIONS/INTERPRETATION: In people with type 2 diabetes, the lower mortality rate in first-generation non-Western immigrants compared with native Swedes was reduced over time and was equalised in second-generation immigrants. These findings suggest that acculturation to Western culture may impact ACM and CSM in immigrants with type 2 diabetes but further investigation is needed. Graphical abstract.
目的/假设:非西方移民到欧洲患 2 型糖尿病的风险很高。在这项包括 2 型糖尿病新发病例的全国性研究中,目的是比较第一代和第二代移民与瑞典本地人的全因死亡率(ACM)和特定原因死亡率(CSM)。
通过瑞典处方药物登记处,确定了 2006 年至 2012 年间瑞典新诊断为药物治疗的 2 型糖尿病患者。他们在 2016 年 12 月 31 日之前接受 ACM 随访,在 2012 年 12 月 31 日之前接受 CSM 随访。分析根据诊断时的年龄、性别、社会经济地位、教育、治疗和地区进行了调整。使用 Cox 回归分析评估相关性。
2006 年至 2012 年间,共有 138085 人被诊断为 2 型糖尿病,并符合纳入标准。其中,102163 人(74.0%)为瑞典本地人,28819 人(20.9%)为第一代移民,7103 人(5.1%)为第二代移民,其父母一方或双方均出生在瑞典以外的国家。第一代移民的 ACM 率较低(HR 0.80 [95% CI 0.76, 0.84])。出生在非西方地区的人的死亡率特别低(0.46 [0.42, 0.50];中东地区,0.41 [0.36, 0.47];亚洲地区,0.53 [0.43, 0.66];非洲地区,0.47 [0.38, 0.59];拉丁美洲地区,0.53 [0.42, 0.68])。ACM 率随着移民年龄的增长和在瑞典居住时间的缩短而降低。与瑞典本地人相比,在瑞典居住时间≤24 年的第一代移民(0.55 [0.51, 0.60])的 ACM 率低于在瑞典居住时间>24 年的移民(0.92 [0.87, 0.97])。第二代移民的生存率并不优于瑞典本地人,而是对于父母双方均出生在国外的移民,ACM 率较高(1.28 [1.05, 1.56])。
结论/解释:在患有 2 型糖尿病的人群中,第一代非西方移民的死亡率低于瑞典本地人,但这种差异随着时间的推移而降低,在第二代移民中则趋于平衡。这些发现表明,向西方文化的文化同化可能会影响患有 2 型糖尿病的移民的 ACM 和 CSM,但需要进一步研究。